RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma
Fangfang Jiao(Shanghai Medical College of Fudan University), Rui Guo(Shanghai Medical College of Fudan University), Chris Jones(North Carolina State University), Hongjie Shen(Soochow University), Gensheng Yang(Zhejiang University of Technology), Chen He(St. Jude Children's Research Hospital), Yujiang Geno Shi(Shanghai Medical College of Fudan University), Yang Shi(Wuhan University), Yong‐Chun Yu(Fudan University), Jamie N. Anastas(Baylor College of Medicine), Jiajun Cai(Fudan University), Ze Li(Huaihua University), Tingting Liu(Anhui Medical University), Fei Lan(Shanghai Medical College of Fudan University), Ying Mao(Fudan University), Yanhui Xu(Shanghai Medical College of Fudan University), Wenqi Xu(Fudan University), Suzanne J. Baker(St. Jude Children's Research Hospital)
Cited by 34
Related Papers
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
|Science|1989|2.1k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657